(Q36532419)

14 August 2017

1 reference

title

Epidemiology of Hepatitis B virus and genotype (English)

1 reference

14 August 2017

1 reference

1 reference

1 reference

Jean-Pierre Allain

1

1 reference

14 August 2017

1 May 2006

1 reference

Journal of Clinical Virology

14 August 2017

1 reference

14 August 2017

36 Suppl 1

1 reference

14 August 2017

S12-7

1 reference

Occult hepatitis B virus infection: implications in transfusion

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Hepatitis B virus genotypes and precore mutations in Scottish blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Identification of different states of hepatitis B virus infection with a quantitative PCR assay

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Hepatitis B virus persistence after recovery from acute viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Determinación del genotipo del virus de la hepatitis B y detección de mutaciones de resistencia al tratamiento con lamivudina

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

[Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)]

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

NAT for HBV and anti-HBc testing increase blood safety

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Comparison of the sensitivity of NAT using pooled donor samples for HBV and that of a serologic HBsAg assay

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Cote d'Ivoire: complete genome sequence and phylogenetic relatedness of HBV genotype E.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

Real time TaqMan PCR detection and quantitation of HBV genotypes A-G with the use of an internal quantitation standard.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2980003-X

7 January 2021

10.1016/S1386-6532(06)80003-X

Identifiers

DOI

1 reference

release_hjvpl5nkwff5vh4ewpw6bpdcdi

14 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hjvpl5nkwff5vh4ewpw6bpdcdi

24 November 2022

mapped directly with Wikidata item

PubMed ID

16831687

1 reference

PubMed ID

16831687